28
Oct
2025

Shiratori Pharmaceutical Japan

Exhibitor at CPHI Frankfurt 2025 stand 11.0B26, API
About Us

Shiratori Pharmaceutical is an API manufacturer in Japan focusing on APIs in niche markets such as rare diseases, rare oncology, neurology, etc. including high potency APIs. Manufacturing patents have been applied for Tafamidis and Eltrombopag in Japan.
Please find API pipeline below:
- Trametinib
- Cabazitaxel Acetonate
- Opicapone
- Ixazomib Citrate
- Brexpiprazole
- Valbenazine Tosilate
- Esaxerenone
- Pemafibrate
- Omidenepag
- Daprodustat- Macitentan
- Riociguat
- Selexipag
- Tafamidis

  • JP
  • 2020
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Primary activities
API Producer
Contact info
  • JBSL Kanda Building 7F, 12 Kanda Higashi Matsushita, 101-0042, Chiyoda-ku, Tokyo-to, Japan
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 11.0B26, API

Products Featured at CPHI Frankfurt 2025